Security Benefit Life Insurance Company’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Security Benefit Life Insurance Company’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-64,709	Closed	-$291	–	25
2024 Q3	$291	Hold	64,709	–	–	﹤0.01%	26
2024 Q2	$1.82K	Hold	64,709	–	–	﹤0.01%	25
2024 Q1	$5.82K	Hold	64,709	–	–	﹤0.01%	28
2023 Q4	$6.81K	Hold	64,709	–	–	﹤0.01%	28
2023 Q3	$14.6K	Hold	64,709	–	–	﹤0.01%	27
2023 Q2	$17K	Hold	64,709	–	–	﹤0.01%	33
2023 Q1	$11.6K	Hold	64,709	–	–	﹤0.01%	47
2022 Q4	$12.9K	Hold	64,709	–	–	﹤0.01%	41
2022 Q3	$47K	Hold	64,709	–	–	﹤0.01%	35
2022 Q2	$34K	Buy	+64,709	New	+$41K	﹤0.01%	50
2022 Q1	–	Sell	-64,709	Closed	-$145K	–	40
2021 Q4	$145K	Hold	64,709	–	–	0.01%	49
2021 Q3	$219K	Buy	+64,709	New	+$230K	0.01%	120

Other funds holding DNA.WS

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

HIA

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

NewSquare Capital Newtown Square, Pennsylvania $1.35B AUM 34.37% 1-Year Est. Return

Security Benefit Life Insurance Company's DNA.WS Position: Q4 2024 in Review

Security Benefit Life Insurance Company sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q4 2024, closing a stake of 64,709 shares — an estimated $291 sold.

Security Benefit Life Insurance Company first reported a position in DNA.WS in Q3 2021 and held it in 12 quarters. The position peaked at $219K in Q3 2021. 3 funds tracked by Wall St. Rank hold DNA.WS as of Q4 2024.

Security Benefit Life Insurance Company reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q4 2024 after selling out during the quarter.
Security Benefit Life Insurance Company sold 64,709 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q4 2024, an estimated $291.
Security Benefit Life Insurance Company first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q3 2021 and held it in 12 quarters.
Security Benefit Life Insurance Company's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $219K in Q3 2021.
3 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q4 2024.

Based on Security Benefit Life Insurance Company's 13F filing for Q4 2024, filed 4 Feb 2025.